BTX 1801 is we on the way, page-60

it would be interesting to know how many products got issued with QIDP last year. they wouldn't be handing that out to everyone, so you would think the FDA would also have some certainty about the success of the drug perhaps as well?
It also adds a serious amount of extra value. Doubling the exclusivity for the product from 5-10 years. A lot of example takeovers have also only been for the 5 year exclusivity of a single product (we have 3 potential products)
The market sizes they have been suggesting are in the hundreds of millions to billions of dollars annually over the next couple of years and increasing exponentially. by 2050 AMR are going to cost the global economy more than $100trillion dollars and kill more people than cancer, figures provided by WHO as per Vinnie's video in September. it's also a treatment not a cure so everyone would use it prior to going to hospital to prevent getting staph after an operation etc I would think. so even if you don't have staph you still use it as a preventative? so by year ten the world market size would be huge. just my opinion.